drugset / Trial / NCT01470417
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the role of Gemcitabine and Abraxane in the treatment of resectable and borderline-resectable pancreatic cancer by giving the chemotherapy before surgery.
Timeline
- Start
- 2011-10
- Primary completion
- 2014-01
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Comparator | Nab-paclitaxel | Small molecule | 100 mg/m2 | Intravenous |